FR23C1048I1 - Agonistes de recepteur de ghreline pour la traitemnet de la cachexia - Google Patents
Agonistes de recepteur de ghreline pour la traitemnet de la cachexiaInfo
- Publication number
- FR23C1048I1 FR23C1048I1 FR23C1048C FR23C1048C FR23C1048I1 FR 23C1048 I1 FR23C1048 I1 FR 23C1048I1 FR 23C1048 C FR23C1048 C FR 23C1048C FR 23C1048 C FR23C1048 C FR 23C1048C FR 23C1048 I1 FR23C1048 I1 FR 23C1048I1
- Authority
- FR
- France
- Prior art keywords
- cachexia
- treatment
- receptor agonists
- ghrelin receptor
- ghrelin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010006895 Cachexia Diseases 0.000 title 1
- 102000000393 Ghrelin Receptors Human genes 0.000 title 1
- 108010016122 Ghrelin Receptors Proteins 0.000 title 1
- 239000000018 receptor agonist Substances 0.000 title 1
- 229940044601 receptor agonist Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Nutrition Science (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010043484 | 2010-02-26 | ||
| PCT/JP2011/054556 WO2011105611A1 (ja) | 2010-02-26 | 2011-02-28 | 悪液質を治療するためのグレリン受容体作動物質 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FR23C1048I1 true FR23C1048I1 (fr) | 2024-01-19 |
Family
ID=44507004
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR23C1048C Active FR23C1048I1 (fr) | 2010-02-26 | 2023-12-18 | Agonistes de recepteur de ghreline pour la traitemnet de la cachexia |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US10975070B2 (pt) |
| EP (1) | EP2540721B1 (pt) |
| JP (1) | JPWO2011105611A1 (pt) |
| KR (1) | KR20120131183A (pt) |
| CN (1) | CN102762564B (pt) |
| BR (1) | BR112012020377B1 (pt) |
| CA (1) | CA2789750C (pt) |
| ES (1) | ES2615731T3 (pt) |
| FR (1) | FR23C1048I1 (pt) |
| HK (1) | HK1174615A1 (pt) |
| MX (1) | MX341660B (pt) |
| RU (1) | RU2012141061A (pt) |
| WO (1) | WO2011105611A1 (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3524260T3 (da) * | 2012-09-27 | 2023-10-09 | Elanco Animal Health Incorporated | Farmaceutiske sammensætninger til behandling af manglende appetit |
| TWI629982B (zh) * | 2013-05-28 | 2018-07-21 | 拉夸里亞創藥股份有限公司 | 多晶型形式 |
| TW201625613A (zh) * | 2014-10-31 | 2016-07-16 | 拉夸里亞創藥股份有限公司 | 作為生長激素釋放肽受體激動劑之四氫吡唑並吡啶衍生物 |
| JP6467513B2 (ja) * | 2015-01-28 | 2019-02-13 | アラタナ セラピューティクス、 インコーポレイテッド | 体重増加用化合物の長期使用のための組成物と方法 |
| WO2022065831A1 (ko) * | 2020-09-22 | 2022-03-31 | 경북대학교 산학협력단 | 그렐린 수용체 작용제로서의 트리아졸 화합물의 용도 |
| CN115778960A (zh) * | 2022-08-19 | 2023-03-14 | 广州六顺生物科技有限公司 | 一种杂芳环衍生物在制备治疗或预防恶病质药物中的应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4997984A (en) | 1989-12-19 | 1991-03-05 | Shawa Denko K.K. | Process for preparation of N-(α-alkoxyethyl)-carboxylic acid amide |
| TW432073B (en) * | 1995-12-28 | 2001-05-01 | Pfizer | Pyrazolopyridine compounds |
| EP1159964B1 (en) | 2000-05-31 | 2009-10-28 | Pfizer Products Inc. | Use of growth hormone secretagogues for stimulating gastrointestinal motility |
| IL145106A0 (en) * | 2000-08-30 | 2002-06-30 | Pfizer Prod Inc | Intermittent administration of a geowth hormone secretagogue |
| EP2389941A1 (en) * | 2004-08-18 | 2011-11-30 | Elixir Pharmaceuticals, Inc. | Growth-hormone secretagogues |
| JP2007063225A (ja) * | 2005-09-01 | 2007-03-15 | Takeda Chem Ind Ltd | イミダゾピリジン化合物 |
| EA200970764A1 (ru) * | 2007-02-13 | 2010-04-30 | ХЕЛСИНН ТЕРАПЬЮТИКС (Ю. Эс.), ИНК. | Способ лечения расстройств, вызванных пролиферацией клеток, с применением стимуляторов секреции гормона роста |
| WO2008153027A1 (ja) * | 2007-06-11 | 2008-12-18 | Takeda Pharmaceutical Company Limited | ピロロキノリン誘導体およびその用途 |
| WO2009063993A1 (ja) * | 2007-11-15 | 2009-05-22 | Takeda Pharmaceutical Company Limited | 縮合ピリジン誘導体およびその用途 |
| WO2009139340A1 (ja) | 2008-05-12 | 2009-11-19 | 武田薬品工業株式会社 | ピラゾール化合物 |
| DK3524260T3 (da) | 2012-09-27 | 2023-10-09 | Elanco Animal Health Incorporated | Farmaceutiske sammensætninger til behandling af manglende appetit |
-
2011
- 2011-02-28 WO PCT/JP2011/054556 patent/WO2011105611A1/ja active Application Filing
- 2011-02-28 RU RU2012141061/04A patent/RU2012141061A/ru not_active Application Discontinuation
- 2011-02-28 CA CA2789750A patent/CA2789750C/en active Active
- 2011-02-28 JP JP2012501911A patent/JPWO2011105611A1/ja active Pending
- 2011-02-28 KR KR1020127024117A patent/KR20120131183A/ko not_active Application Discontinuation
- 2011-02-28 EP EP11747565.7A patent/EP2540721B1/en active Active
- 2011-02-28 CN CN201180009948.8A patent/CN102762564B/zh active Active
- 2011-02-28 ES ES11747565.7T patent/ES2615731T3/es active Active
- 2011-02-28 BR BR112012020377-0A patent/BR112012020377B1/pt active IP Right Grant
- 2011-02-28 US US13/580,479 patent/US10975070B2/en active Active
- 2011-02-28 MX MX2012009774A patent/MX341660B/es active IP Right Grant
-
2013
- 2013-01-31 HK HK13101402.5A patent/HK1174615A1/xx unknown
-
2021
- 2021-03-02 US US17/189,552 patent/US20210179613A1/en not_active Abandoned
-
2023
- 2023-12-18 FR FR23C1048C patent/FR23C1048I1/fr active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN102762564B (zh) | 2015-09-30 |
| CA2789750A1 (en) | 2011-09-01 |
| HK1174615A1 (en) | 2013-06-14 |
| US10975070B2 (en) | 2021-04-13 |
| MX341660B (es) | 2016-08-29 |
| MX2012009774A (es) | 2012-10-05 |
| JPWO2011105611A1 (ja) | 2013-06-20 |
| WO2011105611A1 (ja) | 2011-09-01 |
| BR112012020377A8 (pt) | 2018-01-02 |
| CN102762564A (zh) | 2012-10-31 |
| KR20120131183A (ko) | 2012-12-04 |
| US20210179613A1 (en) | 2021-06-17 |
| EP2540721A4 (en) | 2013-08-07 |
| BR112012020377A2 (pt) | 2016-05-10 |
| BR112012020377B1 (pt) | 2019-10-08 |
| EP2540721B1 (en) | 2016-12-14 |
| CA2789750C (en) | 2018-03-06 |
| EP2540721A1 (en) | 2013-01-02 |
| US20120322821A1 (en) | 2012-12-20 |
| ES2615731T3 (es) | 2017-06-08 |
| RU2012141061A (ru) | 2014-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR23C1048I1 (fr) | Agonistes de recepteur de ghreline pour la traitemnet de la cachexia | |
| ES1070518Y (es) | Dispositivo nivelador para la colocacion de piezas de recubrimiento | |
| EP2680853A4 (en) | TREATMENT OF CANCER WITH DOPAMINE RECEPTOR ANTAGONISTS | |
| UA22227S (uk) | Пристрій для обробляння води | |
| DK2558105T3 (da) | Bardoxolonmethyl til behandling af fedme | |
| DK3718509T3 (da) | Vævsanker til annuloplastikindretning | |
| DK2613819T4 (da) | Smørende belægninger til medicinske anordninger | |
| DK2821407T3 (da) | Piperidinoncarboxamidazaindan-cgrp receptorantagonister | |
| FR2978343B1 (fr) | Organe d'ancrage pour materiel d'osteosynthese vertebrale | |
| SI2627328T1 (sl) | Kombinacije agonistov receptorjev serotonina za zdravljenje motenj premikanja | |
| FR2968538B1 (fr) | Prothese pour membre inferieur | |
| PL2649068T3 (pl) | Pochodne eteru oksazolilowo-metylowego jako agoniści receptora ALX | |
| IT1401941B1 (it) | Dispositivo per imbarcazioni | |
| HRP20150974T1 (en) | 2-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as vegf receptor kinase inhibitors | |
| HK1204286A1 (en) | Ghrelin receptor agonists for the treatment of achlorhydria | |
| EP2533780A4 (en) | 5-HT4 RECEPTOR AGONISTS FOR THE TREATMENT OF DEMENTIA | |
| EP2276345A4 (en) | SMALL MOLECULAR INHIBITORS OF THE ANDROGEN RECEPTOR | |
| FR2971425B1 (fr) | Dispositif de radioprotection pour seringue | |
| FR2931916B1 (fr) | Isolant pour bague | |
| DE112011104236A5 (de) | Knochenverankerungseinrichtung | |
| DK2391366T3 (da) | Substituerede benzimidazoler til behandling af astrocytomer | |
| DK2597959T3 (da) | Fremgangsmåde og indretning til afskalning af bløddyr | |
| FR2959769B1 (fr) | Dispositif de verrouillage pour un vantail semi-fixe | |
| IT1403028B1 (it) | Dispositivo per disabili | |
| HK1202459A1 (en) | Use of ghrelin receptor inverse agonists or antagonists for treating sleep disorders |